Cargando…

Partial breast irradiation: why and how

Detalles Bibliográficos
Autores principales:	Calvo, FA, Díaz, JA, Montero, Á, González, A Álvarez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231896/ http://dx.doi.org/10.1186/bcr1216

Ejemplares similares

Radiotherapy in early stage invasive breast cancer: current tendencies
por: Diaz-Gonzalez, JA, et al.
Publicado: (2005)

Immediate versus delayed repair of partial mastectomy defects in breast conservation
por: Kronowitz, SJ, et al.
Publicado: (2009)

Breast interventional devices: how they evolve and define new subspecialities
por: Burbank, F
Publicado: (2006)

Premalignancy in the human breast: how is it defined, is morphology good enough?
por: Gusterson, BA
Publicado: (2003)

Patient safety: why do things go wrong?
por: Flin, R
Publicado: (2004)

Symptomatic breast services in Ireland: how do they compare with national and international standards?
por: O'Leary, D, et al.
Publicado: (2011)

Why allergen detection by ELISA is insufficient to protect allergic consumers
por: Popping, B
Publicado: (2013)

Growth hormone responsiveness: why does it vary and can it be predicted?
por: Cutfield, Wayne S
Publicado: (2015)

O048 Why don’t Australians with Private Health Insurance Prioritise their Sleep Health?
por: Sweet, A, et al.
Publicado: (2023)

Partial nail avulsion: habit or evidence based?
por: Solanki, Priten, et al.
Publicado: (2011)

Dying feet in ICU: why might extracorporeal membrane oxygenation machines cause necrotic feet?
por: Martin, Helen V, et al.
Publicado: (2013)

Understanding why edema in salvaged myocardium is difficult to detect by late gadolinium enhancement
por: Ugander, Martin, et al.
Publicado: (2012)

Designing the CORONIS trial. Why a non-regular fractional factorial design?
por: Hardy, Pollyanna, et al.
Publicado: (2013)

40 years of anorexia nervosa: why we should never give up
por: Hill, Stephanie, et al.
Publicado: (2014)

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
por: Schelleman, Hedi, et al.
Publicado: (2015)

Who do treatments work for and why? Understanding treatment-effect mechanisms in stratified medicine
por: Emsley, Richard, et al.
Publicado: (2013)

If MIAVR is so good, why aren't we all doing it? A UK perspective
por: Smyth, Justin
Publicado: (2013)

Holding onto power: why confidence intervals are not (usually) the best basis for sample size calculations
por: Metcalfe, Chris
Publicado: (2011)

Beyond total treatment effects in RCTs: why we need to measure outcomes at baseline when investigating mediation
por: Landau, Sabine, et al.
Publicado: (2015)

How spiculation affects the likelihood of malignancy in screen-detected masses: a review of 974 masses excised in the first 8 years of the East Sussex, Brighton & Hove Breast Screening Service
por: Horn, S, et al.
Publicado: (2004)

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
por: Klijn, JGM, et al.
Publicado: (2005)

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer
por: Colomer, R, et al.
Publicado: (2005)

How to get doctors to hand hygiene: nudge nudge
por: Kwok, A, et al.
Publicado: (2015)

Mid-term impact of patient-prosthesis mismatch on young and middle-aged patients undergoing surgery due to severe aortic stenosis
por: Hernandez-Vaquero, D, et al.
Publicado: (2013)

Partial inhibition of HIV replication by type-I interferons: impact of cell-to-cell viral transfer
por: Vendrame, Daniela, et al.
Publicado: (2009)

Correlation between end-tidal and arterial carbon dioxide partial pressure in patients undergoing craniotomy
por: Hemmati, Naser, et al.
Publicado: (2012)

Can we recruit to expertise trials? Experience from the total or partial knee arthroplasty trial (TOPKAT)
por: Davies, Loretta, et al.
Publicado: (2013)

The contribution of health systems research to HSR: time to know what we are talking about, and why it is important for evidence-based policy-making
por: Busse, Reinhard
Publicado: (2014)

High risk feet in subacute rehabilitation facilities: how many are there?
por: Earl, Brenton J, et al.
Publicado: (2013)

How commonly do children with cerebral arteriopathy have renovascular disease?
por: Willsher, A, et al.
Publicado: (2012)

How local is the local field potential?
por: Lindén, Henrik, et al.
Publicado: (2011)

O055 NIV titration: How to Match Ventilator Settings to the Patient?
por: Ridgers, A, et al.
Publicado: (2023)

Molecular control of apoptosis in the breast
por: Streuli, C, et al.
Publicado: (2000)

Genomic profiling of breast cancer
por: Borg, Å
Publicado: (2005)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Promoting early breast cancer presentation in women after their final routine breast screening mammogram
por: Ramirez, A
Publicado: (2006)

How are symptomatic services run in the United Kingdom?
por: Monypenny, I
Publicado: (2006)

How to prevent SAM in mitral valve reconstruction
por: Cocora, M, et al.
Publicado: (2013)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission
por: Butler, LM, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qa8s3ctkup1r16sb5405ge94c3